Baker Bros. Advisors (GP) LLC, Director, 10% Owner at Prelude Therapeutics Inc (PRLD), bought 5,626,581 shares at $19.00 ($30.0M) on 2020-09-29, disclosed to the SEC on 2020-09-30.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 4,047,634 | $0 | 0.0% |
| 2 | $19.00 | 104,628 | $2.0M | 6.6% |
| 3 | $19.00 | 1,474,319 | $28.0M | 93.4% |
| Total | $5.33 avg | 5,626,581 | $30.0M | 100% |
| Filing → |
| KOD | BUY | 2026-09-30 | $63.4M | — | Filing → |
| TRDA | BUY | 2025-11-12 | $2.6M | — | Filing → |
| CELC | BUY | 2025-09-10 | $19.1M | — | Filing → |